sXeraLi (@sXeraM) header
sXeraLi (@sXeraM) profile picture

Professional knife catcher

Mars
Joined October 2016
Photo by sXeraLi (@sXeraM)Photo by sXeraLi (@sXeraM)Photo by sXeraLi (@sXeraM)Photo by sXeraLi (@sXeraM)Photo by sXeraLi (@sXeraM)Photo by sXeraLi (@sXeraM)Photo by sXeraLi (@sXeraM)Photo by sXeraLi (@sXeraM)Photo by sXeraLi (@sXeraM)Photo by sXeraLi (@sXeraM)
sXeraLi retweeted
There’s a collection of free projects on GitHub that are already capable of replacing quite a few tools you’re paying for monthly. 1. TradingAgents An AI multi-agent quantitative trading framework github.com/TauricResearch… 2. LibreChat One interface for accessing multiple models, including ChatGPT, Claude, and Gemini github.com/danny-avila/Li… 3. HyperFrames HeyGen An open-source video generation engine github.com/heygen-com/hyp… 4. Fincept Terminal An open-source version of the Bloomberg Terminal github.com/Fincept-Corpor… 5. MoneyPrinterTurbo Generate short videos with AI in one click github.com/harry0703/Mone… 6. Agentic Inbox Cloudflare An open-source AI email assistant github.com/cloudflare/age… 7. VoxCPM An AI voice cloning tool github.com/OpenBMB/VoxCPM 8. Flowsint An open-source OSINT intelligence analysis tool github.com/reconurge/flow… 9. agent-skills A skill library for Claude Code github.com/addyosmani/age… 10. Nango An open-source API integration platform github.com/NangoHQ/nango Follow @abir35627 These aren’t toy projects. For many tools you’re still paying for monthly, someone on GitHub has already built an open-source alternative. Stop just bookmarking AI tool websites. A lot of the stuff that actually works is on GitHub.
26
90
1
182
5,520
Çin, her birinin imalatı 1 yıl süren, tanesi 300 milyon dolar olan ultraviyole litografi makinesini üretmeyi başardı. 3 nm çip üretimi için kullanılan bu makineyi dünyada yalnızca Avrupa’nın en değerli şirketi olan Hollandalı ASML üretiyordu. ASML bu makinelerden yılda sadece 45-50 adet kadar üretebiliyor. Bu şirkette de 1000’in üzerinde Türk mühendis çalışıyor. 45-50 adet olduğuna bakmayın. Makine dediğimiz, torna makinesi gibi bir şey değil. Her bir makine ayrı bir odada üretiliyor. Bu makineler metrelerce boyunda. Üretim yapan mühendisler bile özel kıyafetlerle odaya giriyor. Çok hassas bir ortamda üretim yapılıyor. Hata payı sıfır olmak zorunda. Tayvanlı TSMC de bu makinelerle gelişmiş çipler üretiyor. Hem TSMC’yi hem de ASML’yi, daha çok mini ev aletleri ve tıraş makineleri üretmesiyle tanıdığımız Philips ortak olarak kuruyor. Ama bu makineleri Çin’e satmıyorlar. Hatta Huawei telefon pazarında liderliği ele geçireceği sırada Amerika’nın baskısıyla çip satmayı da bırakıyorlar. Böylece Apple zirveyi korumaya devam ediyor. Çin ise baskılandıkça daha da güçlenen bir toplum olduğu için bu makineyi üretmeyi kafasına koyuyor. Haberlere göre Çin, bir dönem ASML’de çalışıp emekli olan mühendisleri bir araya getiriyor. Bu ekip de gelişmiş çip üretiminde kullanılan EUV litografi makinesinin ilk prototipini yapıyor. 2030’a kadar da ticarileşmesi bekleniyor. Ama perde arkasına baktığımızda iş o kadar da kolay değil. Ekipler kendi içlerinde bile izole edilmiş. Yani toplamda 1.000 mühendis var diyelim; 10’ar kişilik gruplara ayrılmışlar. Bir grup, diğer grubun ne üzerinde çalıştığını bilmiyor. Proje tamamen gizlilik içinde yürütülüyor ve Çin için kritik öneme sahip. Hatta çok kritik alanlarda çalışan bazı mühendislerin dış dünyayla bağlantıları da kesilmiş. Telefon kullanımları son derece sınırlıymış. Bir de şöyle bir şey var. Çin, farklı alanlarda kendi buluşu olan teknolojilerin mühendislerini muhtemelen yurt dışına göndermiyor, yurt dışına çıkmalarını yasaklıyor. Çünkü paranın satın alamayacağı güç yok. Kendileri çok sık kopyalama yaptıkları için bu konuda çok tedirgin olsalar gerek. Diğer yandan muhtemelen 10 yıla kalmaz bu sektörü de ele geçirirler. Çip üretiminin en kritik makinesi olan EUV litografi sistemlerinden, Avrupa’nın en değerli şirketi olan ASML bile yılda yaklaşık 50 adet üretebiliyor. Çin yılda kaç tane üretir hesap edin. Bu adamların zekası, azmi ve kopyalama yeteneği gerçekten bambaşka…
Japonya bugün dünyanın süper gücü olabilirdi. 1985'te yapılan bir hata her şeyi değiştirdi. 1985'te Japonya dünyanın fabrikasıydı. Amerikan şirketleri Japon rakipleriyle rekabet edemiyordu. Otomotivde, elektronikte, yarı iletkenlerde. Japonya her sektörde öndeydi. Dünyanın en büyük 10 bankasının 7'si Japondu. Japon şirketler Amerikan gayrimenkullerini satın alıyordu. Rockefeller Center bir Japon şirkete satıldı. Amerika'da Japonya karşıtlığı doruk noktasına ulaşmıştı. Tıpkı bugünkü Çin gibi. Bugün Çin'in yaptığı her şeyi o dönem Japonya yapıyordu. Daha ucuz üretiyordu. Amerikan pazarını ele geçiriyordu. Sonra bir anlaşma imzalandı. Japonya'nın parası güçlendirildi. İhracat bir anda çöktü. Buraya kadar çoğu kişi biliyor. Ama asıl hikaye bundan sonra başlıyor. Japonya üretmeyi bıraktı. Merkez bankası ekonomiyi kurtarmak için faizi sıfıra indirdi. Japonya'nın gücü üretimden geliyordu ama artık üretim kâr etmiyordu. Para güçlü, ürünler pahalı, müşteri azalmış. Şirketler üretmek yerine finansal mühendisliğe yöneldi. Gayrimenkule yatırdı. Borsaya yatırdı. Spekülatif varlıklara yatırdı. Fabrikalar boşalmaya başladı. Üretim daha ucuz ülkelere taşındı. Normalde kâr edemeyen bir şirket batar. Batması gereken şirket batarsa kaynaklar yeni şirketlere gider. Ekonomi yenilenir. Japonya bunu yapmadı. Batması gereken şirketleri ayakta tuttu. Bankalar kötü kredileri silmek yerine sakladı. Kâr etmeyen şirketlere kredi vermeye devam etti. Bu şirketler üretmiyordu. Büyümüyordu. Ama batmıyordu. Ekonominin kaynakları yeni şirketlere gitmek yerine bu ölü şirketleri yaşatmak için harcandı. Bu seçim onlarca yıla mal oldu. Japonya artık üreten ülke değildi. Borç veren ülkeye dönüşmüştü. Dünya Japonya'dan sıfır faizle yen borç aldı. Bu parayı ABD tahvillerine, Amerikan borsasına, başka ülkelerin varlıklarına yatırdı. Dünyanın en büyük fonları bunu yaptı. Japonya'nın parası Japonya'da kalmadı. Başkalarını zenginleştirdi. Üreten ülke zenginleşir. Para içeride kalır, istihdam yaratır, teknoloji geliştirir. Borç veren ülkenin parası dışarı akar, başkalarını zenginleştirir. 1985'te dünyanın 2. büyük ekonomisiydi. 2024'te Almanya geçti, 4.'ye düştü. 2026'da Hindistan geçiyor, 5.'ye düşüyor. Japonya'nın potansiyeli devasa idi. Üretim gücü, teknolojisi, disiplini vardı. Bu potansiyelle bugün dünyanın süper gücü olabilirdi. Ama üretmeyi bıraktı. Üretmeyi bırakan ekonomi ayakta kalamaz. Japonya bunun en büyük kanıtı. Sen bu konu hakkında ne düşünüyorsun?
172
517
29
3,622
735,293
sXeraLi retweeted
Something I don’t understand: NVIDIA designs the GPUs. TSMC manufactures them. ASML makes the machines used to manufacture them. If ASML is clearly more powerful Why we only hear about NVIDIA and why is Nvidia worth more than ASML? @grok, explain this.
187
95
18
2,409
920,886
I am begging you, put an open source AI on your phone this weekend. It's one free app and a 2 to 4GB model, and it runs on the phone you already own. No account, no subscription, and it keeps working in airplane mode. When your signal drops, your AI app stops working. This one keeps answering on a plane, on a train or in the middle of nowhere. Install PocketPal AI from the App Store or Google Play, tap Models, and download Gemma or Qwen. Setup takes about 10 minutes. You'll be glad it's there the first time you have no signal and need an answer.
182
224
26
3,613
599,575
Europe in a nutshell 😂
142
2,493
223
8,153
375,486
sXeraLi retweeted
2/10 $VRT – Data center cooling & power. Every new AI cluster needs more of it. 3/10 $MU – HBM memory is the real bottleneck right now. 4/10 $ON – Power chips for AI servers and next-gen 800V designs. 5/10 $GEV – Turbines and grid tech that must scale with AI electricity demand. 6/10 $MPWR – High-efficiency power management inside AI racks. 7/10 $COHR – Optical components moving data at AI speeds. 8/10 $BE – Fast-deploy fuel cells when the grid can’t keep up. 9/10 $FIX – The contractors actually installing all the power & cooling. 10/10 $ENTG – Critical materials for advanced AI chip manufacturing. The loud names get the hype. The boring ones that fix the real bottlenecks often make the money. Which one is still the most under-appreciated? Follow me for more high-conviction AI infrastructure ideas before they get crowded.
1
4
42
7,918
These 8 sectors represent the top picks to own right now: Space: 1. $RKLB 2. $SPCX Photonics: 1. $AXTI 2. $AAOI 3. $CRDO 4. $LITE 5. $COHR Drones/Robotics: 1. $ONDS 2. $OUST Software/Fintech: 1. $HOOD 2. $PLTR 3. $NOW AI Infrastructure: 1. $NBIS 2. $IREN 3. $CIFR Semiconductor: 1. $AEHR 2. $PENG 3. $INTC 4. $AVGO Storage: 1. $SNDK 2. $DRAM 3. $MU Robotics: 1. $OUST 2. $TSLA Nuclear: 1. $OKLO 2. $VST Bookmark this for later! If you are not following us with notifications turned on, you might miss our next alerts.
1
37
145
11,328
I made this for you bro ❤️
522
1,561
120
10,715
316,192
sXeraLi retweeted
Role: Act as a senior, skeptical biotech equity analyst. Your goal is to evaluate a list of ticker symbols against 7 strict, quantitative criteria. Rules of Engagement: Search Requirement: You MUST search recent SEC filings (10-K, 10-Q), earnings call transcripts, clinical trial registries (ClinicalTrials.gov), and independent analyst reports. No PR Fluff: Do not accept management's marketing language (e.g., "best-in-class", "massive opportunity") as fact. You must find the underlying data (p-values, exact cash amounts, patient population math) to verify it. Cite Your Sources: For every "Pass", "Fail", or "Caution", you must provide a specific data point and the approximate source (e.g., "Q2 2026 10-Q", "Recent AACR presentation"). Step-by-Step: Evaluate each criterion one by one. Do not skip or merge criteria. The 7 Criteria: Proven Management: C-suite has a documented track record of prior FDA approvals, successful Phase 3 trials, or prior biotech exits. Diverse Pipeline: At least 2 distinct clinical-stage assets, preferably with different Mechanisms of Action (MoA) or targeting different indications, to mitigate single-asset binary risk. Best/First in Class Data: Recent Phase 2/3 data shows statistical significance (p < 0.05) on primary endpoints, with clear, documented differentiation from the Standard of Care (SoC) in efficacy, safety, or convenience. Flag as "Caution" if Phase 2 data is solely biomarker-driven without clinical outcomes. Defined Milestone: Lead asset has unequivocally met Phase 2 primary endpoints, and the company is actively in Phase 3, preparing an NDA/BLA, or generating early commercial revenue. Clean Balance Sheet: Minimum of 18–24 months of cash runway at the current quarterly burn rate, OR net-cash positive (Cash & Equivalents > Total Debt). Flag any major convertible debt maturities or warrant overhangs within the next 12 months. Attractive Valuation Proxy: Market Cap should ideally be under $15B to ensure a margin of safety. For pre-revenue: Enterprise Value (Market Cap + Debt - Cash) is close to or less than Net Cash. For late-stage: EV/Peak Sales multiple is < 3x based on conservative, independent estimates. Blockbuster Potential (≥$5B Single Asset OR Sum-of-the-Parts): The lead asset must have a verifiable path to ≥$5B in annual peak sales. Crucial: Do not anchor solely on the initial rare disease indication; actively search for broader, adjacent indications that could push estimates >5B. Alternatively, if the lead asset is niche(<2B), the company must have a diversified pipeline of at least 2-3 other clinical assets that, in aggregate, credibly project to >$5B in combined peak sales. Output Format: For EACH ticker, provide: Ticker & Company Name Criterion 1-7 Breakdown: [Pass / Fail / Caution] - [1 sentence with specific data point and source] Overall Verdict: [Strong Pass / Pass with Caveats / Hard Fail] Top Risk: [1 sentence on the biggest fundamental threat to the thesis] Here are the tickers to analyze: [Insert Tickers Here]
3
16
288
25,151
One of the best ways to find the next big winners is to follow earnings growth. 10 stocks with the strongest earnings growth cycles: 1. $ALAB | Q3 2026 revenue surged 154% YoY.
4
12
72
18,764
sXeraLi retweeted
You do understand why this could ignite the BIGGEST RALLY in AI optics yet, right? 🚨Bernstein forecasts InP supply to surge 60% in 2027 and another 67% in 2028, with $AXTI delivering the majority, yet supply still can't catch demand. In the same research, Bernstein estimates $NVDA Rubin Ultra shipments will expand $NVDA's optical ecosystem by 91% in 2028, from roughly $24.5B in 2027 to $46.8B in 2028, driving 70% to 90% annual InP optical demand growth. You can already see that wafer scarcity in $AXTI's financials: Revenue climbed from $26.9M in Q1 2026 to $47.6M in Q2 and $73.4M in Q3, pushing GAAP gross margin from 29.6% to 56.0%, with commercial backlog above $500M and Q4 revenue guided to roughly $90M. Downstream US laser makers are paying years ahead to lock in supply. $LITE posted a 42.3% Non-GAAP operating margin in Q1 FY27, landed over $5B in NPO and CPO purchase commitments, and wired $AXTI a $43.5M wafer prepayment. $COHR signed a 5-year $20B PhotonLink deal anchored by 400mW CW lasers, with Bernstein putting its Rubin Ultra opportunity at $9.4B in 2027 and $36.1B in 2028. What makes China central to this trade is that it sits on both ends of the bottleneck. $AXTI's main production base is Beijing Tongmei in China, which signed $285M to $545M in private equity financing to expand InP capacity, and wafers shipped inside China require zero export permits. Riding that local demand, Chinese InP laser maker Yuanjie Technology (688498 SH) grew 9M 2026 revenue 320% YoY to RMB 1.61B (~$241M) and net profit 867% YoY to RMB 1.02B (~$154M) at an 81.7% gross margin. Every layer of this chain is expanding into pre-committed orders, with customers helping fund the buildout upfront. $AXTI $COHR $LITE $NVDA
9
13
3
143
28,134
sXeraLi retweeted
50 Sites That Show What Billionaires Buy and Read for Free🤯 1.) dataroma.com → Current portfolios of famous investors 2.) whalewisdom.com → Quarterly fund trades 3.) capitoltrades.com → Stock transactions of US politicians 4.) openinsider.com → Executives' own company stocks 5.) 13f.info → Making fund filings readable 6.) sec.gov/edgar → Companies' official reports 7.) berkshirehathaway.com → Buffett's letters since 1977 8.) buffett.cnbc.com → Video archive of Buffett meetings 9.) oaktreecapital.com → Howard Marks' investor memos 10.) bridgewater.com → Research from Ray Dalio's firm 11.) principles.com → Dalio's principles for free 12.) gmo.com → Jeremy Grantham's market notes 13.) aqr.com → Quantitative fund research 14.) pages.stern.nyu.edu/~adamoda… → Damodaran's valuation data 15.) aswathdamodaran.blogspot.com → Valuation professor's blog 16.) collabfund.com/blog → Morgan Housel's money writings 17.) fs.blog → Mental models for decision-making 18.) am.jpmorgan.com → JPMorgan's free market guide 19.) ark-invest.com/research → Innovation-focused fund research 20.) a16z.com → Venture capital essays 21.) csinvesting.org → Value investing lecture notes 22.) gsb.columbia.edu/valueinvest… → Columbia's value investing archive 23.) fred.stlouisfed.org → Fed's economic data archive 24.) federalreserve.gov → Fed decisions and statements 25.) ecb.europa.eu → European Central Bank data 26.) bis.org → Reports from the central bank of central banks 27.) tradingeconomics.com → Countries' economic indicators 28.) macrotrends.net → Companies' long-term charts 29.) stockanalysis.com → Company financials for free 30.) companiesmarketcap.com → Companies' market cap rankings 31.) finviz.com → Stock screener and heat map 32.) portfoliovisualizer.com → Portfolio backtesting 33.) tradingview.com → Charts and market analysis 34.) koyfin.com → Professional market screener 35.) annualreports.com → Company activity reports archive 36.) investor.gov → SEC's investor education site 37.) bogleheads.org/wiki → Passive investing encyclopedia 38.) investopedia.com → Financial terms dictionary 39.) corporatefinanceinstitute.co… → Free finance guides 40.) cfainstitute.org → CFA research publications 41.) morningstar.com → Fund and stock evaluations 42.) simplywall.st → Companies' visual analysis 43.) valueinvestorsclub.com → Archive of selected investment theses 44.) etfdb.com → Seeing what's inside funds 45.) curvo.eu → European fund backtests 46.) ofdollarsanddata.com → Investment writings with data 47.) awealthofcommonsense.com → Market history notes 48.) theirrelevantinvestor.com → Investor psychology writings 49.) visualcapitalist.com → Explaining the economy with charts 50.) ourfiniteworld? → (see note) The rich don't hoard information. They just don't tell you where it is. Save it, follow @Liyana_Coder you'll need it. Not investment advice. @Liyana_Coder
23
252
8
864
43,053
The AI 100: Top Private AI Companies The first AI 100 ranking by Newcomer and Bessemer, by category: • AI Applications — 26: Stripe, Ramp, Sierra… • Developer Platforms — 22: Databricks, Cognition, Fireworks… • Physical World — 19: Waymo, Anduril, Applied Intuition… • Foundation Models — 11: Anthropic, OpenAI, ElevenLabs… • Compute & Infrastructure — 11: Crusoe, Lambda, Fluidstack… • Creative AI — 6: Canva, Higgsfield, Suno… • AI Data & Evaluation — 3: Mercor, Handshake, Arena • Biotech — 2: Isomorphic Labs, Chai Discovery Applications and developer platforms together take 48 of the 100 spots. Only 11 companies build foundation models, yet Anthropic and OpenAI hold the top two places. Physical World is the third-largest group with 19 names — robotics, autonomy and defense are now a core part of the AI map. Data source 🔗 ai100.newcomer.co
1
5
1
43
7,023
sXeraLi retweeted
If you’re under 55 this dip is a buying opportunity $BE: Makes fuel cells that power AI data centers. $CRDO: Makes high-speed cables connecting AI servers. $NBIS: Builds AI data centers and rents Nvidia GPUs. $VRT: Provides cooling and power systems for AI data centers. $VST: Generates electricity to power AI data centers. $MRVL: Designs custom AI chips and networking technology for data centers. $LITE: Makes optical components that transmit data using light inside AI data centers. My share 2 to 3 potential stocks every week, complete with precise entry and exit price points to help you never miss a great investment opportunity! If you find this recommendation helpful, please like, follow, and share! DM me "STOCK" to get more in depth information about the stock
11
67
6
339
33,548
sXeraLi retweeted
Elon warned that over 200 AI data center companies face “guppy level death and consolidation.” @grok give me the no BS answer. Which are the guppies in this list and list others not included.
7
4
51
97,136
Everything Nvidia Depends One critic thing is missing:)
89
7
296
18,736
Breaking: Renaissance Technologies just filed its Q3 2026 13F They sold 99.7% of their Nvidia $NVDA, weeks before the Jensen Huang scandal Here’s everything you need to know about its recent 13F Top 10 positions: 1. Micron $MU: $1.62B 2. Advanced Micro Devices $AMD: $1.21B 3. United Therapeutics $UTHR: $908M 4. Intel $INTC: $835M 5. Alphabet $GOOGL: $828M 6. UnitedHealth $UNH: $817M 7. Exelixis $EXEL: $747M 8. VeriSign $VRSN: $649M 9. SpaceX $SPCX: $621M 10. Corcept Therapeutics $CORT: $559M New positions: • SpaceX $SPCX: $621M • Bank of America $BAC: $351M • Goldman Sachs $GS: $245M • VanEck Semiconductor ETF $SMH: $186M • Booking Holdings $BKNG: $183M Biggest adds: • SanDisk $SNDK: +5,451% shares • Micron $MU: +619% shares • UnitedHealth $UNH: +507% shares • Advanced Micro Devices $AMD: +140% shares Biggest trims: • Nvidia $NVDA: -99.7% shares, was $1.42B • Meta $META: -99.9% shares, was $1.14B • Apple $AAPL: -99.8% shares, was $459M • Amazon $AMZN: -99.5% shares, was $546M • Palantir $PLTR: -71% shares, was $883M Full exits: • Blackstone $BX: was $185M • S&P 500 ETF $SPY: was $164M • Marvell $MRVL: was $151M • Danaher $DHR: was $145M Summary: Renaissance dumped almost all of its Nvidia, Meta, Apple and Amazon and moved the money into memory chips, AMD and SpaceX
137
708
99
4,919
954,908
sXeraLi retweeted
With Claude Whiteboards, talk through a messy plan and Claude lays it out on a board your team can edit. With Claude Sheets, ask for a tracker or a budget and you get a working spreadsheet you can all keep building. In beta on paid plans.
64
138
64
3,469
930,418